Global Recombinant Immunotherapeutics Sales Market Report 2021

August 2016 | 109 pages | ID: G918FCE2B72EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Recombinant Immunotherapeutics

Revenue, means the sales value of Recombinant Immunotherapeutics


This report studies sales (consumption) of Recombinant Immunotherapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering

• Amgen
• AstraZeneca
• Baxter
• Britannia
• Capricor
• CSL Behring
• GlaxoSmithKline
• Grifols
• Ferring
• Janssen
• NeuroDerm
• Octapharma
• Roche
• Rhythm Metabolic
• scPharmceuticals
• SteadyMed
• Takeda
• United Therapeutics
• UCB
• US Worldmeds

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Recombinant Immunotherapeutics in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• Southeast Asia
• India

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Recombinant Immunotherapeutics in each application, can be divided into

• Medical care
• Hospital
• Application 3

Contents

Global Recombinant Immunotherapeutics Sales Market Report 2021

1 RECOMBINANT IMMUNOTHERAPEUTICS OVERVIEW

1.1 Product Overview and Scope of Recombinant Immunotherapeutics
1.2 Classification of Recombinant Immunotherapeutics
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Applications of Recombinant Immunotherapeutics
  1.3.1 Medical care
  1.3.2 Hospital
  1.3.3 Application
1.4 Recombinant Immunotherapeutics Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Recombinant Immunotherapeutics (2011-2021)
  1.5.1 Global Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
  1.5.2 Global Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
  1.5.3 Global Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)

2 GLOBAL RECOMBINANT IMMUNOTHERAPEUTICS COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

2.1 Global Recombinant Immunotherapeutics Market Competition by Manufacturers
  2.1.1 Global Recombinant Immunotherapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)
  2.1.2 Global Recombinant Immunotherapeutics Revenue and Share by Manufacturers (2015 and 2016)
2.2 Global Recombinant Immunotherapeutics (Volume and Value) by Type
  2.2.1 Global Recombinant Immunotherapeutics Sales and Market Share by Type (2011-2021)
  2.2.2 Global Recombinant Immunotherapeutics Revenue and Market Share by Type (2011-2021)
2.3 Global Recombinant Immunotherapeutics (Volume and Value) by Regions
  2.3.1 Global Recombinant Immunotherapeutics Sales and Market Share by Regions (2011-2021)
  2.3.2 Global Recombinant Immunotherapeutics Revenue and Market Share by Regions (2011-2021)
2.4 Global Recombinant Immunotherapeutics (Volume) by Application

3 NORTH AMERICA RECOMBINANT IMMUNOTHERAPEUTICS (VOLUME, VALUE AND SALES PRICE

3.1 North America Recombinant Immunotherapeutics Sales and Value (2011-2021)
  3.1.1 North America Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
  3.1.2 North America Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
  3.1.3 North America Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
3.2 North America Recombinant Immunotherapeutics Sales and Market Share by Manufacturers
3.3 North America Recombinant Immunotherapeutics Sales and Market Share by Type
3.4 North America Recombinant Immunotherapeutics Sales and Market Share by Applications

4 CHINA RECOMBINANT IMMUNOTHERAPEUTICS (VOLUME, VALUE AND SALES PRICE

4.1 China Recombinant Immunotherapeutics Sales and Value (2011-2021)
  4.1.1 China Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
  4.1.2 China Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
  4.1.3 China Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
4.2 China Recombinant Immunotherapeutics Sales and Market Share by Manufacturers
4.3 China Recombinant Immunotherapeutics Sales and Market Share by Type
4.4 China Recombinant Immunotherapeutics Sales and Market Share by Applications

5 EUROPE RECOMBINANT IMMUNOTHERAPEUTICS (VOLUME, VALUE AND SALES PRICE

5.1 Europe Recombinant Immunotherapeutics Sales and Value (2011-2021)
  5.1.1 Europe Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
  5.1.2 Europe Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
  5.1.3 Europe Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
5.2 Europe Recombinant Immunotherapeutics Sales and Market Share by Manufacturers
5.3 Europe Recombinant Immunotherapeutics Sales and Market Share by Type
5.4 Europe Recombinant Immunotherapeutics Sales and Market Share by Applications

6 JAPAN RECOMBINANT IMMUNOTHERAPEUTICS (VOLUME, VALUE AND SALES PRICE

6.1 Japan Recombinant Immunotherapeutics Sales and Value (2011-2021)
  6.1.1 Japan Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
  6.1.2 Japan Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
  6.1.3 Japan Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
6.2 Japan Recombinant Immunotherapeutics Sales and Market Share by Manufacturers
6.3 Japan Recombinant Immunotherapeutics Sales and Market Share by Type
6.4 Japan Recombinant Immunotherapeutics Sales and Market Share by Applications

7 SOUTHEAST ASIA RECOMBINANT IMMUNOTHERAPEUTICS (VOLUME, VALUE AND SALES PRICE

7.1 Southeast Asia Recombinant Immunotherapeutics Sales and Value (2011-2021)
  7.1.1 Southeast Asia Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
  7.1.2 Southeast Asia Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
  7.1.3 Southeast Asia Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
7.2 Southeast Asia Recombinant Immunotherapeutics Sales and Market Share by Manufacturers
7.3 Southeast Asia Recombinant Immunotherapeutics Sales and Market Share by Type
7.4 Southeast Asia Recombinant Immunotherapeutics Sales and Market Share by Applications

8 INDIA RECOMBINANT IMMUNOTHERAPEUTICS (VOLUME, VALUE AND SALES PRICE

8.1 India Recombinant Immunotherapeutics Sales and Value (2011-2021)
  8.1.1 India Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
  8.1.2 India Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
  8.1.3 India Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
8.2 India Recombinant Immunotherapeutics Sales and Market Share by Manufacturers
8.3 India Recombinant Immunotherapeutics Sales and Market Share by Type
8.4 India Recombinant Immunotherapeutics Sales and Market Share by Applications

9 GLOBAL RECOMBINANT IMMUNOTHERAPEUTICS MANUFACTURERS ANALYSIS

9.1 Amgen
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Recombinant Immunotherapeutics Product Type and Technology
    9.1.2.1 Type I
    9.1.2.2 Type II
  9.1.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.2 AstraZeneca
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Recombinant Immunotherapeutics Product Type and Technology
    9.2.2.1 Type I
    9.2.2.2 Type II
  9.2.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.3 Baxter
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Recombinant Immunotherapeutics Product Type and Technology
    9.3.2.1 Type I
    9.3.2.2 Type II
  9.3.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.4 Britannia
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Recombinant Immunotherapeutics Product Type and Technology
    9.4.2.1 Type I
    9.4.2.2 Type II
  9.4.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.5 Capricor
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Recombinant Immunotherapeutics Product Type and Technology
    9.5.2.1 Type I
    9.5.2.2 Type II
  9.5.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.6 CSL Behring
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Recombinant Immunotherapeutics Product Type and Technology
    9.6.2.1 Type I
    9.6.2.2 Type II
  9.6.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Company One (2015 and 2016)
9.7 GlaxoSmithKline
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Recombinant Immunotherapeutics Product Type and Technology
    9.7.2.1 Type I
    9.7.2.2 Type II
  9.7.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Company One (2015 and 2017)
9.8 Grifols
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Recombinant Immunotherapeutics Product Type and Technology
    9.8.2.1 Type I
    9.8.2.2 Type II
  9.8.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Company One (2015 and 2018)
9.9 Ferring
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Recombinant Immunotherapeutics Product Type and Technology
    9.9.2.1 Type I
    9.9.2.2 Type II
  9.9.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Company One (2015 and 2019)
9.10 Janssen
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Recombinant Immunotherapeutics Product Type and Technology
    9.10.2.1 Type I
    9.10.2.2 Type II
  9.10.3 Recombinant Immunotherapeutics Sales, Revenue, Price of Company One (2015 and 2021)
9.11 NeuroDerm
9.12 Octapharma
9.13 Roche
9.14 Rhythm Metabolic
9.15 scPharmceuticals
9.16 SteadyMed
9.17 Takeda
9.18 United Therapeutics
9.19 UCB
9.20 US Worldmeds

10 RECOMBINANT IMMUNOTHERAPEUTICS TECHNOLOGY AND DEVELOPMENT TREND

10.1 Recombinant Immunotherapeutics Technology Analysis
10.2 Recombinant Immunotherapeutics Technology Development Trend

11 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Recombinant Immunotherapeutics
Table Classification of Recombinant Immunotherapeutics
Figure Global Sales Market Share of Recombinant Immunotherapeutics by Type in 2015
Table Applications of Recombinant Immunotherapeutics
Figure Global Sales Market Share of Recombinant Immunotherapeutics by Applications in 2015
Figure Medical care Examples
Figure Hospital Examples
Figure North America Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure China Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure Europe Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure Japan Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure India Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Table Global Recombinant Immunotherapeutics Sales, Revenue and Price (2011-2021)
Figure Global Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
Figure Global Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Table Global Recombinant Immunotherapeutics Sales of Key Manufacturers (2015 and 2016)
Table Global Recombinant Immunotherapeutics Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Recombinant Immunotherapeutics Sales Share by Manufacturers
Figure 2016 Recombinant Immunotherapeutics Sales Share by Manufacturers
Table Global Recombinant Immunotherapeutics Revenue by Manufacturers (2015 and 2016)
Table Global Recombinant Immunotherapeutics Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Recombinant Immunotherapeutics Revenue Share by Manufacturers
Table 2016 Global Recombinant Immunotherapeutics Revenue Share by Manufacturers
Table Global Recombinant Immunotherapeutics Sales and Market Share by Type (2011-2021)
Table Global Recombinant Immunotherapeutics Sales Share by Type (2011-2021)
Figure Sales Market Share of Recombinant Immunotherapeutics by Type (2011-2021)
Figure Global Recombinant Immunotherapeutics Sales Growth Rate by Type (2011-2021)
Table Global Recombinant Immunotherapeutics Revenue and Market Share by Type (2011-2021)
Table Global Recombinant Immunotherapeutics Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Recombinant Immunotherapeutics by Type (2011-2021)
Figure Global Recombinant Immunotherapeutics Revenue Growth Rate by Type (2011-2021)
Table Global Recombinant Immunotherapeutics Sales and Market Share by Regions (2011-2021)
Table Global Recombinant Immunotherapeutics Sales Share by Regions (2011-2021)
Figure Sales Market Share of Recombinant Immunotherapeutics by Regions (2011-2021)
Figure Global Recombinant Immunotherapeutics Sales Growth Rate by Regions (2011-2021)
Table Global Recombinant Immunotherapeutics Revenue and Market Share by Regions (2011-2021)
Table Global Recombinant Immunotherapeutics Revenue Share by Regions (2011-2021)
Figure Revenue Market Share of Recombinant Immunotherapeutics by Regions (2011-2021)
Figure Global Recombinant Immunotherapeutics Revenue Growth Rate by Regions (2011-2021)
Table Global Recombinant Immunotherapeutics Sales and Market Share by Application (2011-2021)
Table Global Recombinant Immunotherapeutics Sales Share by Application (2011-2021)
Figure Sales Market Share of Recombinant Immunotherapeutics by Application (2011-2021)
Figure Global Recombinant Immunotherapeutics Sales Growth Rate by Application (2011-2021)
Figure North America Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
Figure North America Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure North America Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
Table North America Recombinant Immunotherapeutics Sales by Manufacturers (2015 and 2016)
Table North America Recombinant Immunotherapeutics Market Share by Manufacturers (2015 and 2016)
Table North America Recombinant Immunotherapeutics Sales by Type (2015 and 2016)
Table North America Recombinant Immunotherapeutics Market Share by Type (2015 and 2016)
Table North America Recombinant Immunotherapeutics Sales by Applications (2015 and 2016)
Table North America Recombinant Immunotherapeutics Market Share by Applications (2015 and 2016)
Figure Europe Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
Figure Europe Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure Europe Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
Table Europe Recombinant Immunotherapeutics Sales by Manufacturers (2015 and 2016)
Table Europe Recombinant Immunotherapeutics Market Share by Manufacturers (2015 and 2016)
Table Europe Recombinant Immunotherapeutics Sales by Type (2015 and 2016)
Table Europe Recombinant Immunotherapeutics Market Share by Type (2015 and 2016)
Table Europe Recombinant Immunotherapeutics Sales by Applications (2015 and 2016)
Table Europe Recombinant Immunotherapeutics Market Share by Applications (2015 and 2016)
Figure China Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
Figure China Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure China Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
Table China Recombinant Immunotherapeutics Sales by Manufacturers (2015 and 2016)
Table China Recombinant Immunotherapeutics Market Share by Manufacturers (2015 and 2016)
Table China Recombinant Immunotherapeutics Sales by Type (2015 and 2016)
Table China Recombinant Immunotherapeutics Market Share by Type (2015 and 2016)
Table China Recombinant Immunotherapeutics Sales by Applications (2015 and 2016)
Table China Recombinant Immunotherapeutics Market Share by Applications (2015 and 2016)
Figure Japan Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
Figure Japan Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure Japan Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
Table Japan Recombinant Immunotherapeutics Sales by Manufacturers (2015 and 2016)
Table Japan Recombinant Immunotherapeutics Market Share by Manufacturers (2015 and 2016)
Table Japan Recombinant Immunotherapeutics Sales by Type (2015 and 2016)
Table Japan Recombinant Immunotherapeutics Market Share by Type (2015 and 2016)
Table Japan Recombinant Immunotherapeutics Sales by Applications (2015 and 2016)
Table Japan Recombinant Immunotherapeutics Market Share by Applications (2015 and 2016)
Figure India Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
Figure India Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure India Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
Table India Recombinant Immunotherapeutics Sales by Manufacturers (2015 and 2016)
Table India Recombinant Immunotherapeutics Market Share by Manufacturers (2015 and 2016)
Table India Recombinant Immunotherapeutics Sales by Type (2015 and 2016)
Table India Recombinant Immunotherapeutics Market Share by Type (2015 and 2016)
Table India Recombinant Immunotherapeutics Sales by Applications (2015 and 2016)
Table India Recombinant Immunotherapeutics Market Share by Applications (2015 and 2016)
Figure Southeast Asia Recombinant Immunotherapeutics Sales and Growth Rate (2011-2021)
Figure Southeast Asia Recombinant Immunotherapeutics Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Recombinant Immunotherapeutics Sales Price Trend (2011-2021)
Table Southeast Asia Recombinant Immunotherapeutics Sales by Manufacturers (2015 and 2016)
Table Southeast Asia Recombinant Immunotherapeutics Market Share by Manufacturers (2015 and 2016)
Table Southeast Asia Recombinant Immunotherapeutics Sales by Type (2015 and 2016)
Table Southeast Asia Recombinant Immunotherapeutics Market Share by Type (2015 and 2016)
Table Southeast Asia Recombinant Immunotherapeutics Sales by Applications (2015 and 2016)
Table Southeast Asia Recombinant Immunotherapeutics Market Share by Applications (2015 and 2016)
Table Amgen Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Amgen (2015 and 2016)
Table AstraZeneca Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of AstraZeneca (2015 and 2016)
Table Baxter Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Baxter (2015 and 2016)
Table Britannia Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Britannia (2015 and 2016)
Table Capricor Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Capricor (2015 and 2016)
Table CSL Behring Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of CSL Behring (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Grifols Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Grifols (2015 and 2016)
Table Ferring Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Ferring (2015 and 2016)
Table Janssen Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Janssen (2015 and 2016)
Table NeuroDerm Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of NeuroDerm (2015 and 2016)
Table Octapharma Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Octapharma (2015 and 2016)
Table Roche Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Roche (2015 and 2016)
Table Rhythm Metabolic Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Rhythm Metabolic (2015 and 2016)
Table scPharmceuticals Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of scPharmceuticals (2015 and 2016)
Table SteadyMed Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of SteadyMed (2015 and 2016)
Table Takeda Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of Takeda (2015 and 2016)
Table United Therapeutics Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of United Therapeutics (2015 and 2016)
Table UCB Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of UCB (2015 and 2016)
Table US Worldmeds Basic Information List
Table Recombinant Immunotherapeutics Sales, Revenue, Price of US Worldmeds (2015 and 2016)